Ceelie 2013.
Study characteristics | ||
Methods | RCT, parallel groups | |
Participants | 71 infants admitted to a level 3 pediatric intensive care unit in Netherlands
|
|
Interventions |
|
|
Outcomes | Primary: cumulative morphine dose (i.e. the sum of the intraoperative loading dose, the morphine study dose, and the rescue morphine doses) Secondary: morphine rescue dose (microgram/kg) in the first 48 postoperative hours; number of extra rescue morphine doses and infusions; number of patients receiving rescue doses; pain scores (NRS‐11, COMFORT‐B); morphine‐related adverse effects (need for mechanical ventilation or/and reintubation, apnea, naloxone administration, bradycardia, hypotension, seizures, gastrointestinal adverse effects, urinary retention) |
|
Notes | Authors had nothing to declare. Funding source: ZonMw Priority Medicines for Children grant |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Quote: "Patients had an equal probability of assignment to study groups. Stratified randomization was used in combination with random permuted blocks." |
Allocation concealment (selection bias) | Unclear risk | Quote: "A hospital pharmacist carried out computer randomization in advance, and codes were safely stored. (...) A new randomization schedule was computer generated by the same pharmacist. Only the pharmacist had access to group allocation during the study period, for preparation of study medication." |
Blinding of participants and personnel (performance bias) All outcomes | Low risk | Quote: "When patients were randomized to receive paracetamol (30 mg/kg per day in 4 doses), a placebo infusion of normal saline was administered continuously at the same rate as an equivalent morphine infusion. When randomized to receive morphine (...), normal saline was administered 4 times daily as placebo in a volume similar to the intravenous paracetamol dose. Placebos could not be distinguished from the active study drug in color, odor, or viscosity." |
Blinding of outcome assessment (detection bias) All outcomes | Low risk | Quote: "The clinical personnel (blinded as per the previous point) were outcome assessors. Also, "The pharmacist and the statistician performed this interim evaluation after inclusion of 20 patients; the pharmacist, statistician, and investigators remained blinded." |
Incomplete outcome data (attrition bias) All outcomes | Low risk | Data reported for all assessed infants |
Selective reporting (reporting bias) | Unclear risk | Some of the secondary outcomes planned in the trial registry (www.trialregister.nl/trial/1378) were not reported, for example, saliva cortisol levels |
Other bias | Low risk | None |